8-KMaterial AgreementsFinancial EventsExhibits & Filings

STRYKER CORP 8-K Report, Material Agreement (Mar 10, 2016)

Filed March 10, 2016For Securities:SYK

Summary

Stryker Corporation (SYK) filed an 8-K on March 10, 2016, reporting the completion of a significant public offering of notes totaling $3.5 billion. This debt issuance includes four series with varying maturities and coupon rates: 2.000% Notes due 2019, 2.625% Notes due 2021, 3.500% Notes due 2026, and 4.625% Notes due 2046. The primary purpose of this capital raise is to fund two major acquisitions: $2.775 billion for the acquisition of Sage Products Holdings II, LLC, and remaining proceeds, along with cash on hand, for the acquisition of Physio-Control International, Inc. The filing also details the terms of the notes, including interest payment schedules, maturity dates, and special mandatory redemption provisions tied to the Sage Acquisition. Investors should note the strategic deployment of capital towards significant M&A activities, which signals an intent for growth and market expansion. The notes are governed by an indenture with covenants limiting certain corporate actions, such as incurring specific liens or engaging in sale-and-leaseback transactions. A change of control event coupled with a credit rating downgrade could trigger an offer to repurchase the notes at a premium. The filing also includes legal opinions confirming the validity of the issued notes.

Key Highlights

  • 1Stryker completed a $3.5 billion public offering of senior notes across four series (2019, 2021, 2026, 2046) with coupon rates ranging from 2.000% to 4.625%.
  • 2The net proceeds of approximately $3.453 billion are primarily intended to fund the $2.775 billion acquisition of Sage Products Holdings II, LLC.
  • 3Remaining proceeds, combined with cash, will fund the acquisition of Physio-Control International, Inc.
  • 4The 2021, 2026, and 2046 notes are subject to a special mandatory redemption at 101% of principal plus accrued interest if the Sage Acquisition is not completed by July 29, 2016, or if the related agreement is terminated.
  • 5The 2019 notes are not subject to this special mandatory redemption, providing more flexibility.
  • 6The indenture includes covenants limiting the company's ability to incur liens, engage in sale-and-leaseback transactions, and restricts certain fundamental corporate changes.
  • 7A change of control event combined with a credit rating downgrade below investment grade by both Moody's and S&P would trigger a mandatory offer to repurchase the notes at 101% of principal plus accrued interest.

Frequently Asked Questions

Stryker raised a total of $3.5 billion through the public offering of its notes.

The proceeds are primarily intended to fund two acquisitions: $2.775 billion for Sage Products Holdings II, LLC, and the remainder, along with cash on hand, for the acquisition of Physio-Control International, Inc. A portion is also allocated to repay existing 2.000% notes due September 30, 2016, and for general corporate purposes.

Yes, the 2021, 2026, and 2046 notes are subject to a special mandatory redemption under specific conditions related to the completion of the Sage Acquisition. If the acquisition is not completed by July 29, 2016, or if the agreement is terminated, these notes may be redeemed at 101% of their principal amount plus accrued interest. The 2019 notes are not subject to this special redemption.

The indenture contains covenants that limit Stryker's ability to incur certain liens, engage in specific sale and leaseback transactions, and restricts consolidations, mergers, or transfer of substantially all assets. Additionally, a change of control event coupled with a below investment grade rating from both Moody's and S&P would require Stryker to make an offer to repurchase the notes at 101% of their principal amount plus accrued interest.